Internet Archive Scholar

Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease

Mike van der Have, Marie-Josée J. Mangen, Mirthe E. van der Valk, Hugo M. Smeets, Ad van Bodegraven, Gerard Dijkstra, Herma H. Fidder, Dirk J. de Jong, Marieke Pierik, Cyriel Y. Ponsioen, Andrea E. van der Meulen-de Jong, C. Janneke van der Woude (+10 others)
2014 Inflammatory Bowel Diseases  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (405.2 kB)
https://web.archive.org/web/20210716192111/https://scholarlypublications.universiteitleiden.nl/access/item%3A2992071/view

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

on behalf of the COIN Study Group and the Dutch Initiative on Crohn and Colitis Background: Population aging is expected to result in a substantial additional burden on healthcare resources in the near future. We aimed to assess the current and future impact of aging on direct healthcare costs (DHC) attributed to inflammatory bowel disease (IBD). Methods: Patients with IBD from a Dutch multicenter cohort filled out 3-monthly questionnaires for 2 years. Elderly ($60 yr) and younger patients
more » ... 0 yr) IBD were analyzed for differences in 3-monthly DHC, productivity losses, and out-of-pocket costs. Prevalence rates were obtained from a health insurance database. Estimates of annual DHC and prevalence rates were applied to the total Dutch adult population in 2011 and then projected to 2040, using predicted changes in population demography, prices, and volume. Results: IBD-attributable DHC were lower in elderly than in younger patients with IBD with respect to 3-monthly DHC (€359 versus €978, P , 0.01), productivity losses (€108 versus €456, P , 0.01), and out-of-pocket costs (€40 versus €57, P , 0.01). Between 2011 and 2040, the percentage of elderly IBD patients in the Netherlands has been projected to rise from 24% to 35%. Between 2011 and 2040, DHC of the total IBD population in the Netherlands are projected to increase from €161 to €661 million. Population aging accounted for 1% of this increase, next to rising prices (29%), and volume growth (70%). Conclusions: Population aging has a negligible effect on IBD-attributable DHC of the IBD population in the near future, because the average costs incurred by elderly patients with IBD are considerably lower than those incurred by younger patients with IBD.
doi:10.1097/01.mib.0000442677.55051.03 pmid:24518606 fatcat:d72yryhv4zfrbgpqg3enbkhh7q
Citation

Mike van der Have, Marie-Josée J. Mangen, Mirthe E. van der Valk, Hugo M. Smeets, Ad van Bodegraven, Gerard Dijkstra, Herma H. Fidder, Dirk J. de Jong, Marieke Pierik, Cyriel Y. Ponsioen, Andrea E. van der Meulen-de Jong, C. Janneke van der Woude, Paul C. van de Meeberg, Mariëlle J. L. Romberg-Camps, Cees H. M. Clemens, Jeroen M. Jansen, Nofel Mahmmod, Clemens J. M. Bolwerk, J. Reinoud Vermeijden, Peter D. Siersema, Max Leenders, Bas Oldenburg. "Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease." Inflammatory Bowel Diseases 20.4 (2014) 637-645